INKT: MiNK Therapeutics, Inc. Stock

by  •  • Comments Off on INKT: MiNK Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 36.09
Enterprise Value ($M) 34.49
Book Value ($M) -20.30
Book Value / Share -0.58
Price / Book -1.78
NCAV ($M) -21.19
NCAV / Share -0.61
Price / NCAV -1.70

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.24
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.54
Current Ratio 0.54

Balance Sheet (mrq) ($M)
Current Assets 6.00
Assets 6.89
Liabilities 27.19
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -22.92
Net Income -22.46
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -15.76
Cash from Investing -0.07
Cash from Financing -0.41

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13D Armen Garo H 9.68
05-26 13D/A Agenus Inc 62.50 0.83

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 16,140 67,110 24.05
2024-05-16 12,710 72,126 17.62
2024-05-15 131,071 560,216 23.40
2024-05-14 89,706 633,700 14.16
2024-05-13 383,994 4,583,316 8.38

(click for more detail)

Similar Companies
IMNN – Imunon, Inc. IMTX – Immatics N.V.
INDP – Indaptus Therapeutics, Inc. INM – InMed Pharmaceuticals Inc.
INMB – INmune Bio, Inc.


Financial data and stock pages provided by
Fintel.io